NOV Inc. (NOV) Stock Forecast
NOV analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.50 / 5 from 20 analysts
- Price target
- $22.13 average of analyst targets
- Upside to target
- +16.9% from the latest close
- Next earnings
- October 27, 2026 EPS estimate $0.24
- 52-week range
- $12.76 – $21.71
NOV analyst ratings
20 analystsNumber of analysts at each rating.
NOV price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NOV earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.25 | $0.19 | $0.30 | $0.11 | +127.2% | 13 |
| Current fiscal year (2026) | $0.89 | $0.74 | $1.13 | $0.39 | +128.4% | 14 |
| Next fiscal year (2027) | $1.25 | $0.96 | $1.47 | $0.89 | +40.8% | 14 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NOV revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.19B | $2.11B | $2.22B | +0.8% | 15 |
| Current fiscal year (2026) | $8.66B | $8.33B | $8.75B | −1.0% | 16 |
| Next fiscal year (2027) | $9.09B | $8.26B | $9.39B | +5.0% | 16 |
NOV EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NOV revenue: reported and forecast
NOV EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.25 | $0.24 | $0.25 | $0.25 | $0.25 | +1.1% | 0 up · 1 down |
| Current fiscal year (2026) | $0.80 | $0.87 | $0.89 | $0.89 | $0.89 | +11.8% | 0 up · 3 down |
| Next fiscal year (2027) | $1.27 | $1.26 | $1.26 | $1.26 | $1.25 | −1.5% | 1 up · 3 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NOV earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NOV beat in 4 of 12.
What analysts expect from NOV
20 analysts cover NOV; their consensus rating is buy (3.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $22.13, 16.9% above the latest close of $18.93. Analysts expect earnings of $0.89 per share for 2026, +128.4% from a year earlier. For 2027 the average estimate is $1.25 per share on revenue of $9.1 billion. NOV beat the EPS estimate in 4 of the last 12 quarters.
Related: NOV income statement, NOV key metrics, NOV chart. See the NOV stock overview for the latest quote and news.
NOV forecast FAQ
What is NOV's price target?
The average analyst price target for NOV is $22.13, 16.9% above the latest close of $18.93.
Is NOV a buy, hold or sell?
Of 20 analysts covering NOV, 5 rate it a strong buy, 3 a buy, 10 a hold, 1 a sell and 1 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is NOV's EPS forecast?
Analysts forecast $0.89 per share for 2026 (range $0.74 to $1.13); for 2027 the estimate is $1.25.
What is NOV's revenue forecast?
The average revenue estimate for 2026 is $8.7 billion, growth of −1.0%; for 2027 it is $9.1 billion.
When does NOV report earnings?
NOV is expected to report results for the quarter ending September 30, 2026 on October 27, 2026 after the market closes; the EPS estimate is $0.24.
Does NOV usually beat earnings estimates?
NOV reported EPS at or above the analyst estimate in 4 of the last 12 quarters.